Cargando…

Efficacy of Zanubrutinib in the Treatment of Bing–Neel Syndrome

Detalles Bibliográficos
Autores principales:	Wong, Jonathan, Cher, Lawrence, Griffiths, James, Cohen, Aileen, Huang, Jane, Wang, Lai, Gregory, Gareth, Opat, Stephen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745965/ https://www.ncbi.nlm.nih.gov/pubmed/31723793 http://dx.doi.org/10.1097/HS9.0000000000000155

Ejemplares similares

Bing and Neel Syndrome
por: Jennane, S., et al.
Publicado: (2012)

Bing‐Neel syndrome
por: Davis, Katelynn, et al.
Publicado: (2022)

Bing-Neel Syndrome Successfully Treated with Tirabrutinib
por: Oyama, Takashi, et al.
Publicado: (2022)

Bing-Neel Syndrome: An Initial Manifestation of Waldenstrom Macroglobulinemia
por: Lee, Matthew S, et al.
Publicado: (2021)

Therapeutic Experience of Bing-Neel Syndrome Associated with Waldenstrom's Macroglobulinemia
por: Kim, Hyun Do, et al.
Publicado: (2007)

Bing-Neel Syndrome: Illustrative Cases and Comprehensive Review of the Literature
por: Varettoni, Marzia, et al.
Publicado: (2017)

A Case of Bing–Neel Syndrome Successfully Treated with Ibrutinib
por: O'Neil, Daniel S., et al.
Publicado: (2018)

The Impact of Tirabrutinib Monotherapy for Bing-Neel Syndrome in Waldenström's Macroglobulinemia
por: Sekiguchi, Naohiro
Publicado: (2022)

Erratum to “A Case of Bing–Neel Syndrome Successfully Treated with Ibrutinib”
por: O'Neil, Daniel S., et al.
Publicado: (2018)

Anemia ‐ an initial manifestation of Bing‐Neel syndrome: A case report
por: Yang, Xiaoqian, et al.
Publicado: (2022)

Zanubrutinib: past, present, and future
por: Tam, Constantine S., et al.
Publicado: (2023)

Correction: Zanubrutinib: past, present, and future
por: Tam, Constantine S., et al.
Publicado: (2023)

An Autopsy Case of Bing-Neel Syndrome: Discrepancy between the Radiological and Pathological Findings
por: Matsuda, Sakino, et al.
Publicado: (2019)

Bing-Neel Syndrome: Real-Life Experience in Personalized Diagnostic Approach and Treatment
por: Kotsos, Dimitrios, et al.
Publicado: (2022)

Unique Presentation of Bing–Neel Syndrome With Co-existing Chronic Lymphocytic Leukemia
por: Chmielowiec, Karolina, et al.
Publicado: (2022)

Mixed Diffuse and Tumoral Form of Bing-Neel Syndrome Successfully Treated with Ibrutinib
por: Naveed Ahmad, Junid A., et al.
Publicado: (2023)

Zanubrutinib, Alone and in Combination With Tislelizumab, for the Treatment of Richter Transformation of Chronic Lymphocytic Leukemia
por: Tam, Constantine, et al.
Publicado: (2023)

Zanubrutinib for the treatment of relapsed/refractory hairy cell leukemia
por: Tam, Constantine S., et al.
Publicado: (2023)

Treatment of Bing–Neel syndrome with first line sequential chemoimmunotherapy: A case report
por: Gavriatopoulou, Maria, et al.
Publicado: (2019)

Central Nervous System Involvement by Waldenstrom Macroglobulinemia: A Case Report of the Bing–Neel Syndrome
por: Arjunan, Ananth, et al.
Publicado: (2019)

Waldenstrom Macroglobulinemia Manifesting as Acute Kidney Injury and Bing-Neel Syndrome With Excellent Response to Ibrutinib
por: Jafri, Hassaan, et al.
Publicado: (2021)

Bing-Neel综合征三例报告及文献复习
Publicado: (2017)

Successful treatment with tirabrutinib for relapsed Bing-Neel syndrome following high-dose methotrexate and craniospinal irradiation
por: Saburi, Masuho, et al.
Publicado: (2022)

Diagnosing, imaging, and successfully treating a debilitating case of Bing–Neel syndrome: A multidisciplinary feat
por: Kerley, Robert N., et al.
Publicado: (2023)

Zanubrutinib monotherapy in relapsed/refractory indolent non-Hodgkin lymphoma
por: Phillips, Tycel, et al.
Publicado: (2022)

Molecular associations of response to the new-generation BTK inhibitor zanubrutinib in marginal zone lymphoma
por: Tatarczuch, Maciej, et al.
Publicado: (2023)

P1112: TREATING BING-NEEL SYNDROME USING A TAILORED APPROACH: EXPERIENCE OF A SPECIALIST NEUROHAEMATOLOGY CLINIC
por: Khwaja, J., et al.
Publicado: (2022)

Bing-Neel Syndrome, a Rare Presentation of Waldenström Macroglobulinemia—A Multicenter Report by the Polish Lymphoma Research Group
por: Drozd-Sokołowska, Joanna, et al.
Publicado: (2022)

Pooled safety analysis of zanubrutinib monotherapy in patients with B-cell malignancies
por: Tam, Constantine S., et al.
Publicado: (2022)

Zanubrutinib monotherapy for patients with treatment-naïve chronic lymphocytic leukemia and 17p deletion
por: Tam, Constantine S., et al.
Publicado: (2020)

Primary central nervous system diffuse large B‐cell lymphoma masqueraded as Bing‐Neel syndrome: Steps in management and review of future directions
por: Delasos, Lukas, et al.
Publicado: (2021)

Bing-Neel Syndrome Case Report: A Previously Undocumented IgG Variant with MRI, PET/CT, and PET/MRI Imaging
por: Halperin, Daniel, et al.
Publicado: (2016)

Beneficial Effect of Bendamustine in a Patient with Anti-MAG/SGPG Neuropathy and Bing-Neel Syndrome Associated with Waldenström Macroglobulinemia: A Case Report
por: Ueki, Syugo, et al.
Publicado: (2018)

Bing–Neel Syndrome and Coexisting Pituitary Macroadenoma in a Patient with Waldenström Macroglobulinemia Revealed by (18)F-FDG and (68)Ga-Pentixafor PET/CT
por: Pan, Qingqing, et al.
Publicado: (2023)

Safety and efficacy of zanubrutinib in relapsed/refractory marginal zone lymphoma: final analysis of the MAGNOLIA study
por: Opat, Stephen, et al.
Publicado: (2023)

Crystal‐storing histiocytosis and Bing‐Neel‐like syndrome revealing a small B‐cell lymphoma with plasmacytic differentiation, presumed to be a marginal zone lymphoma
por: Lequain, Hippolyte, et al.
Publicado: (2021)

Current-induced Néel order switching facilitated by magnetic phase transition
por: Wu, Hao, et al.
Publicado: (2022)

P633: UPDATED SAFETY AND EFFICACY RESULTS OF ZANUBRUTINIB IN PATIENTS WITH B-CELL MALIGNANCIES WHO ARE INTOLERANT OF IBRUTINIB AND/OR ACALABRUTINIB
por: Shadman, Mazyar, et al.
Publicado: (2023)

Bing-Neel Syndrome with Detectable MYD88 L265P Gene Mutation as a Late Relapse Following Autologous Hematopoietic Stem Cell Transplantation for Waldenström’s Macroglobulinemia
por: Kopińska, Anna J., et al.
Publicado: (2017)

Zanubrutinib for treatment‐naïve and relapsed/refractory chronic lymphocytic leukaemia: long‐term follow‐up of the phase I/II AU‐003 study
por: Cull, Gavin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cmjmu6gl7obnnqvkcq89bbfkqc